VERO BEACH, Fla., Feb. 19, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced that it will no longer sponsor the 13 C-sucrose breath test ...
Background: Sucrose is widely used to manage procedural pain in term newborns despite a lack of evidence of its effectiveness for different procedures and infant populations. Our objectives were to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results